HEALTHMEDPAGE TODAY
Intensified Pre-Op Chemoradiotherapy Fails in Locally Advanced Rectal Cancer
Adding concurrent irinotecan to capecitabine-based chemoradiotherapy did not improve disease-free survival or other outcomes in a phase III trial for patients with locally advanced rectal cancer.
Mentioned
Related Signal
Adjacent reporting
- Colon cancer breakthrough keeps patients cancer-free for nearly 3 years
- New drug approach offers hope for patients with recurrent aggressive cancers
- Rectal cancer deaths rising up to three times faster in specific age group, study finds
- Rectal cancer deaths rising rapidly among millennials: 'It's a medical crisis'
- Breakthrough pancreatic cancer treatment could double survival time
- Delivering an immune therapy into tumours instead of intravenously reduces adverse effects